FindTrial
Sign In

Can Ropivacaïn 1% replace morphine intrathecal in total hip replacement

Can Ropivacaïn 1% replace morphine intrathecal in total hip replacement - Ropivacain as replacement for morphine intrathecal

Status
Unknown
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31034
Enrollment
20
Registered
2008-12-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

totale heup operatie arthrosis

Interventions

None listed

Sponsors

Sint Franciscus Gasthuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Need to be operated for a total hip repair

Exclusion criteria

Exclusion criteria: Known allergies for ropivacaïne or morphin

Design outcomes

Primary

MeasureTime frame
Pain scores (VAS) Itching Nausea and/ or vomiting Patint satisfaction—

Secondary

MeasureTime frame
none—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)